Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion Delphin

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Antiviral Research|May 4, 2020
Current knowledge on Hepatitis Delta Virus replicationJulie Lucifora, Marion Delphin
Medecine Sciences : M/S|March 3, 2025
[Non-alphabetic viral hepatitis]Florentin Pastor, Marion Delphin, Julie Lucifora, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 22, 2025
Impact of metformin on HBV replication: No evidence of suppression in vitroCyrus Hawkins, Elizabeth Waddilove, Philippa C Matthews, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 14, 2021
How to get away with liver innate immunity? A viruses' taleMarion Delphin, Manon Desmares, Svenja Schuehle, et al.
Viruses|January 22, 2022
Inhibitory Effect of IL-1β on HBV and HDV Replication and HBs Antigen-Dependent Modulation of Its Secretion by MacrophagesMarion Delphin, Suzanne Faure-Dupuy, Nathalie Isorce, et al.
The Journal of Infection|May 23, 2025
Clinical trials for Hepatitis Delta Virus in the WHO African region: A neglected virus among neglected virusesMarion Delphin, James Campbell, Eloi R Verrier, et al.
Antiviral Research|August 13, 2022
Insights on the antiviral mechanisms of action of the TLR1/2 agonist Pam3CSK4 in hepatitis B virus (HBV)-infected hepatocytesManon Desmares, Marion Delphin, Brieux Chardès, et al.
Virology Journal|July 5, 2025
Conserved recombination patterns across hepatitis B genotypes: a retrospective studyDerek Tshiabuila, James E San, Eduan Wilkinson, et al.
Antiviral Research|December 13, 2022
A stable hepatitis D virus-producing cell line for host target and drug discoveryCharlotte Bach, Julie Lucifora, Marion Delphin, et al.
Journal of Virus Eradication|July 4, 2025
HIV PrEP programmes as a framework for diagnosing and treating HBV infection in adolescents and young adults in KwaZulu-Natal, South AfricaGloria Sukali, Jacob Busang, Jaco Dreyer, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Antiviral Research|May 4, 2020
Current knowledge on Hepatitis Delta Virus replicationJulie Lucifora, Marion Delphin
Medecine Sciences : M/S|March 3, 2025
[Non-alphabetic viral hepatitis]Florentin Pastor, Marion Delphin, Julie Lucifora, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 22, 2025
Impact of metformin on HBV replication: No evidence of suppression in vitroCyrus Hawkins, Elizabeth Waddilove, Philippa C Matthews, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 14, 2021
How to get away with liver innate immunity? A viruses' taleMarion Delphin, Manon Desmares, Svenja Schuehle, et al.
Viruses|January 22, 2022
Inhibitory Effect of IL-1β on HBV and HDV Replication and HBs Antigen-Dependent Modulation of Its Secretion by MacrophagesMarion Delphin, Suzanne Faure-Dupuy, Nathalie Isorce, et al.
The Journal of Infection|May 23, 2025
Clinical trials for Hepatitis Delta Virus in the WHO African region: A neglected virus among neglected virusesMarion Delphin, James Campbell, Eloi R Verrier, et al.
Antiviral Research|August 13, 2022
Insights on the antiviral mechanisms of action of the TLR1/2 agonist Pam3CSK4 in hepatitis B virus (HBV)-infected hepatocytesManon Desmares, Marion Delphin, Brieux Chardès, et al.
Virology Journal|July 5, 2025
Conserved recombination patterns across hepatitis B genotypes: a retrospective studyDerek Tshiabuila, James E San, Eduan Wilkinson, et al.
Antiviral Research|December 13, 2022
A stable hepatitis D virus-producing cell line for host target and drug discoveryCharlotte Bach, Julie Lucifora, Marion Delphin, et al.
Journal of Virus Eradication|July 4, 2025
HIV PrEP programmes as a framework for diagnosing and treating HBV infection in adolescents and young adults in KwaZulu-Natal, South AfricaGloria Sukali, Jacob Busang, Jaco Dreyer, et al.
Pageof 3